164 related articles for article (PubMed ID: 36180885)
1. Mucosal-associated invariant T cells predict increased acute graft-versus-host-disease incidence in patients receiving allogeneic hematopoietic stem cell transplantation.
Wang Z; Zhang S; Zhang X; Liu L; Zhou L; Shen Y; Zhang R; He Y; Yang D; Jiang E; Feng X; Zhou J; Cheng T; Han M; Feng S
Cancer Cell Int; 2022 Sep; 22(1):297. PubMed ID: 36180885
[TBL] [Abstract][Full Text] [Related]
2. The Potential Roles of Mucosa-Associated Invariant T Cells in the Pathogenesis of Gut Graft-Versus-Host Disease After Hematopoietic Stem Cell Transplantation.
Gao MG; Hong Y; Zhao XY; Pan XA; Sun YQ; Kong J; Wang ZD; Wang FR; Wang JZ; Yan CH; Wang Y; Huang XJ; Zhao XS
Front Immunol; 2021; 12():720354. PubMed ID: 34539656
[TBL] [Abstract][Full Text] [Related]
3. Influence of post-transplant mucosal-associated invariant T cell recovery on the development of acute graft-versus-host disease in allogeneic bone marrow transplantation.
Kawaguchi K; Umeda K; Hiejima E; Iwai A; Mikami M; Nodomi S; Saida S; Kato I; Hiramatsu H; Yasumi T; Nishikomori R; Kondo T; Takaori-Kondo A; Heike T; Adachi S
Int J Hematol; 2018 Jul; 108(1):66-75. PubMed ID: 29582333
[TBL] [Abstract][Full Text] [Related]
4. Unconventional T Cells Influence Clinical Outcome After Allogeneic Hematopoietic Cell Transplantation.
Siblany L; Stocker N; Ricard L; Brissot E; Duléry R; Banet A; Sestili S; Belhocine R; Van de Wyngaert Z; Bonnin A; Capes A; Ledraa T; Beurier P; Fadel K; Mohty M; Gaugler B; Malard F
J Clin Immunol; 2024 Jun; 44(6):139. PubMed ID: 38822857
[TBL] [Abstract][Full Text] [Related]
5. Regulatory γδ T cells induced by G-CSF participate in acute graft-versus-host disease regulation in G-CSF-mobilized allogeneic peripheral blood stem cell transplantation.
Xuan L; Wu X; Qiu D; Gao L; Liu H; Fan Z; Huang F; Jin Z; Sun J; Li Y; Liu Q
J Transl Med; 2018 May; 16(1):144. PubMed ID: 29801459
[TBL] [Abstract][Full Text] [Related]
6. Graft-Derived Reconstitution of Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation.
Bhattacharyya A; Hanafi LA; Sheih A; Golob JL; Srinivasan S; Boeckh MJ; Pergam SA; Mahmood S; Baker KK; Gooley TA; Milano F; Fredricks DN; Riddell SR; Turtle CJ
Biol Blood Marrow Transplant; 2018 Feb; 24(2):242-251. PubMed ID: 29024803
[TBL] [Abstract][Full Text] [Related]
7. Mucosal-Associated Invariant T Cells Display a Poor Reconstitution and Altered Phenotype after Allogeneic Hematopoietic Stem Cell Transplantation.
Solders M; Erkers T; Gorchs L; Poiret T; Remberger M; Magalhaes I; Kaipe H
Front Immunol; 2017; 8():1861. PubMed ID: 29312341
[TBL] [Abstract][Full Text] [Related]
8. MAIT and Vδ2 unconventional T cells are supported by a diverse intestinal microbiome and correlate with favorable patient outcome after allogeneic HCT.
Andrlová H; Miltiadous O; Kousa AI; Dai A; DeWolf S; Violante S; Park HY; Janaki-Raman S; Gardner R; El Daker S; Slingerland J; Giardina P; Clurman A; Gomes ALC; Nguyen C; da Silva MB; Armijo GK; Lee N; Zappasodi R; Chaligne R; Masilionis I; Fontana E; Ponce D; Cho C; Bush A; Hill L; Chao N; Sung AD; Giralt S; Vidal EH; Hosszu KK; Devlin SM; Peled JU; Cross JR; Perales MA; Godfrey DI; van den Brink MRM; Markey KA
Sci Transl Med; 2022 May; 14(646):eabj2829. PubMed ID: 35613281
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Graft CD3 Cell/Regulatory T Cell Ratio on Acute Graft-versus-Host Disease and Post-Transplantation Outcome: A Prospective Multicenter Study of Patients with Acute Leukemia Undergoing Allogeneic Peripheral Blood Stem Cell Transplantation.
Delia M; Carluccio P; Mestice A; Chiusolo P; Metafuni E; Bellesi S; Arpinati M; Milone GA; Martino M; Mazza P; Ingrosso C; Vacca A; Saporiti G; Zallio F; Attolico I; Pastore D; Specchia G; Albano F; Musto P
Transplant Cell Ther; 2021 Nov; 27(11):918.e1-918.e9. PubMed ID: 34403789
[TBL] [Abstract][Full Text] [Related]
10. Impact of very early CD4(+) /CD8(+) T cell counts on the occurrence of acute graft-versus-host disease and NK cell counts on outcome after pediatric allogeneic hematopoietic stem cell transplantation.
Huttunen P; Taskinen M; Siitonen S; Saarinen-Pihkala UM
Pediatr Blood Cancer; 2015 Mar; 62(3):522-8. PubMed ID: 25417898
[TBL] [Abstract][Full Text] [Related]
11. Graft invariant natural killer T-cell dose predicts risk of acute graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.
Chaidos A; Patterson S; Szydlo R; Chaudhry MS; Dazzi F; Kanfer E; McDonald D; Marin D; Milojkovic D; Pavlu J; Davis J; Rahemtulla A; Rezvani K; Goldman J; Roberts I; Apperley J; Karadimitris A
Blood; 2012 May; 119(21):5030-6. PubMed ID: 22371885
[TBL] [Abstract][Full Text] [Related]
12. [Difference between FOXP3 gene expressions in donor grafts with or without acute graft-versus-host disease].
Wang ZD; Feng SZ; Zhou SY; Wang M; Zhou Z; Zhai WJ; Han MZ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1215-20. PubMed ID: 17204197
[TBL] [Abstract][Full Text] [Related]
13. Circulating mucosal-associated invariant T cell levels and their cytokine levels in healthy adults.
Lee OJ; Cho YN; Kee SJ; Kim MJ; Jin HM; Lee SJ; Park KJ; Kim TJ; Lee SS; Kwon YS; Kim N; Shin MG; Shin JH; Suh SP; Ryang DW; Park YW
Exp Gerontol; 2014 Jan; 49():47-54. PubMed ID: 24269212
[TBL] [Abstract][Full Text] [Related]
14. Reconstitution of Circulating Mucosal-Associated Invariant T Cells after Allogeneic Hematopoietic Cell Transplantation: Its Association with the Riboflavin Synthetic Pathway of Gut Microbiota in Cord Blood Transplant Recipients.
Konuma T; Kohara C; Watanabe E; Takahashi S; Ozawa G; Suzuki K; Mizukami M; Nagai E; Jimbo K; Kaito Y; Isobe M; Kato S; Takahashi S; Chiba A; Miyake S; Tojo A
J Immunol; 2020 Mar; 204(6):1462-1473. PubMed ID: 32041784
[TBL] [Abstract][Full Text] [Related]
15. The absolute number of regulatory T cells in unmanipulated peripheral blood grafts predicts the occurrence of acute graft-versus-host disease post haplo-identical hematopoietic stem cell transplantation.
Ding L; Zhu H; Yang Y; Yan HM; Zhang HH; Han DM; Wang ZD; Zheng XL; Liu J; Zhu L; Mei-Xue ; Guo ZK; Wang HX
Leuk Res; 2017 May; 56():13-20. PubMed ID: 28161606
[TBL] [Abstract][Full Text] [Related]
16. High frequencies of CD62L⁺ naive regulatory T cells in allografts are associated with a low risk of acute graft-versus-host disease following unmanipulated allogeneic haematopoietic stem cell transplantation.
Lu SY; Liu KY; Liu DH; Xu LP; Huang XJ
Clin Exp Immunol; 2011 Aug; 165(2):264-77. PubMed ID: 21635226
[TBL] [Abstract][Full Text] [Related]
17. Pre-transplant donor CD4
Rubio MT; Bouillié M; Bouazza N; Coman T; Trebeden-Nègre H; Gomez A; Suarez F; Sibon D; Brignier A; Paubelle E; Nguyen-Khoc S; Cavazzana M; Lantz O; Mohty M; Urien S; Hermine O
Leukemia; 2017 Apr; 31(4):903-912. PubMed ID: 27740636
[TBL] [Abstract][Full Text] [Related]
18. Peripheral Blood CD38 Bright CD8+ Effector Memory T Cells Predict Acute Graft-versus-Host Disease.
Khandelwal P; Lane A; Chaturvedi V; Owsley E; Davies SM; Marmer D; Filipovich AH; Jordan MB; Marsh RA
Biol Blood Marrow Transplant; 2015 Jul; 21(7):1215-22. PubMed ID: 25881755
[TBL] [Abstract][Full Text] [Related]
19. Platelet and Red Blood Cell Transfusions and Risk of Acute Graft-versus-Host Disease after Myeloablative Allogeneic Hematopoietic Cell Transplantation.
Gjærde LK; Sørensen ALT; von Stemann JH; Fischer-Nielsen A; Hansen MB; Sengeløv H; Ostrowski SR
Transplant Cell Ther; 2021 Oct; 27(10):866.e1-866.e9. PubMed ID: 34252580
[TBL] [Abstract][Full Text] [Related]
20. Nuclear Matrix-associated Protein SMAR1 Attenuated Acute Graft-versus-host Disease by Targeting JAK-STAT Signaling in CD4 + T Cells.
Huang Z; Zhang R; Teng Y; Guo J; Zhang H; Wang L; Tang LV; Shi W; Wu Q; Xia L
Transplantation; 2024 Mar; 108(3):e23-e35. PubMed ID: 37817309
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
